Asano, T.; Tanaka, T.; Suzuki, H.; Li, G.; Ohishi, T.; Kawada, M.; Yoshikawa, T.; Kaneko, M.K.; Kato, Y.
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model. Antibodies 2022, 11, 74.
https://doi.org/10.3390/antib11040074
AMA Style
Asano T, Tanaka T, Suzuki H, Li G, Ohishi T, Kawada M, Yoshikawa T, Kaneko MK, Kato Y.
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model. Antibodies. 2022; 11(4):74.
https://doi.org/10.3390/antib11040074
Chicago/Turabian Style
Asano, Teizo, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K. Kaneko, and Yukinari Kato.
2022. "A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model" Antibodies 11, no. 4: 74.
https://doi.org/10.3390/antib11040074
APA Style
Asano, T., Tanaka, T., Suzuki, H., Li, G., Ohishi, T., Kawada, M., Yoshikawa, T., Kaneko, M. K., & Kato, Y.
(2022). A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model. Antibodies, 11(4), 74.
https://doi.org/10.3390/antib11040074